Analysis of TCGA data revealed consistent findings, which suggested that SPP1+ Macs were associated with poor outcomes and that the SPP1 expression level was positively correlated with cancer stage and tumor grade in HNSCC patients (Fig. 2J; Supplementary Fig. S2B, C). The gene discussed is SPP1; the disease is neoplasm.